PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.\', \'These authors contributed equally.\', \'Hospital Municipal de Emergências Albert Sabin, São Caetano, Brazil.\', \'Hospital Municipal de Barueri Dr Francisco Moran, Barueri, Brazil.\', \'Hospital e Maternidade Therezinha de Jesus, Juiz de Fora, Brazil.\', \'Hospital Santa Casa de Misericórdia de Sorocaba, Sorocaba, Brazil.\', \'Secretaria de Estado de Saúde do Distrito Federal, Brasília, Brazil.\', \'Secretaria Municipal de Saúde de Bauru, Bauru, Brazil.\', \'Secretaria Municipal de Saúde de Guarulhos, Guarulhos, Brazil.\', \'Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.\', \'Brazilian Biosciences National Laboratory (LNBio) and Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil.\', \'Instituto René Rachou - Fiocruz, Belo Horizonte, Brazil.\', \'University of Campinas, UNICAMP, Campinas, Brazil.\', \'Dept of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 200372510.1183/13993003.03725-2020
?:hasPublicationType
?:journal
  • The European respiratory journal
is ?:pmid of
?:pmid
?:pmid
  • 33361100
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all